PTGS2 and cancer: The first study used here for illustrative purposes was conducted by Nagao M et al. [13], who investigated the roles of a prostaglandin endoperoxide synthase (PTGS2) polymorphism and nonsteroidal anti-inflammatory drug (NSAID) intake in the risk of developing cancer.